135 related articles for article (PubMed ID: 9829711)
1. DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes.
Pfau W; Stone EM; Brockstedt U; Carmichael PL; Marquardt H; Phillips DH
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1019-25. PubMed ID: 9829711
[TBL] [Abstract][Full Text] [Related]
2. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
5. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
Li D; Wang M; Dhingra K; Hittelman WN
Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
[TBL] [Abstract][Full Text] [Related]
6. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
[TBL] [Abstract][Full Text] [Related]
7. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.
Zhu J; Chang P; Bondy ML; Sahin AA; Singletary SE; Takahashi S; Shirai T; Li D
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):830-7. PubMed ID: 14504191
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
[TBL] [Abstract][Full Text] [Related]
10. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population.
Topinka J; Binková B; Mracková G; Stávková Z; Peterka V; Benes I; Dejmek J; Lenícek J; Pilcík T; Srám RJ
Environ Mol Mutagen; 1997; 30(2):184-95. PubMed ID: 9329643
[TBL] [Abstract][Full Text] [Related]
11. 32P-postlabelling with high-performance liquid chromatography for analysis of abundant DNA adducts in human tissues.
Yang K; Fang JL; Li D; Chung FL; Hemminki K
IARC Sci Publ; 1999; (150):205-17. PubMed ID: 10626222
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
13. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
[TBL] [Abstract][Full Text] [Related]
14. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
16. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4).
Funk D; Sorg BL; Lindner SC; Schmeiser HH
Environ Mol Mutagen; 2010 May; 51(4):338-43. PubMed ID: 20120015
[TBL] [Abstract][Full Text] [Related]
17. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study.
Peluso M; Airoldi L; Armelle M; Martone T; Coda R; Malaveille C; Giacomelli G; Terrone C; Casetta G; Vineis P
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):341-6. PubMed ID: 9568791
[TBL] [Abstract][Full Text] [Related]
18. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.
Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ
Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660
[TBL] [Abstract][Full Text] [Related]
20. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]